Total Visits

Views
Newly designed hemagglutinin-Der p 2 chimera is a potential candidate for allergen specific immunotherapy113

Total Visits Per Month

November 2023December 2023January 2024February 2024March 2024April 2024May 2024
Newly designed hemagglutinin-Der p 2 chimera is a potential candidate for allergen specific immunotherapy11331127

File Visits

Views
acc_mrkic2018.pdf147

Top country views

Views
South Korea30
United States26
Serbia6
Poland2
China1
Netherlands1
Sweden1

Top cities views

Views
Busan30
Ashburn15
Belgrade4
Des Moines2
Warsaw2
Guangzhou1
Loznica1